Cargando…

Investigation of the Therapeutic Effect of Total Alkaloids of Corydalis saxicola Bunting on CCl(4)-Induced Liver Fibrosis in Rats by LC/MS-Based Metabolomics Analysis and Network Pharmacology

Liver fibrosis is a pathological result of liver injury that usually leads to a pathophysiological wound healing response. The total alkaloids of Corydalis saxicola Bunting (TACS) have been used for hepatoprotective effects on the liver. However, its exact therapeutic mechanisms of liver fibrosis ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Qianyi, Luo, Zhuo, Li, Danfeng, Qin, Jinghua, Pan, Ziping, Guo, Bingjian, Deng, Lijun, Nong, Yunyuan, Huang, Zheng, He, Ying, Guo, Hongwei, Zhu, Dan, Liang, Yonghong, Su, Zhiheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866371/
https://www.ncbi.nlm.nih.gov/pubmed/36676934
http://dx.doi.org/10.3390/metabo13010009
_version_ 1784876073689808896
author Wang, Qianyi
Luo, Zhuo
Li, Danfeng
Qin, Jinghua
Pan, Ziping
Guo, Bingjian
Deng, Lijun
Nong, Yunyuan
Huang, Zheng
He, Ying
Guo, Hongwei
Zhu, Dan
Liang, Yonghong
Su, Zhiheng
author_facet Wang, Qianyi
Luo, Zhuo
Li, Danfeng
Qin, Jinghua
Pan, Ziping
Guo, Bingjian
Deng, Lijun
Nong, Yunyuan
Huang, Zheng
He, Ying
Guo, Hongwei
Zhu, Dan
Liang, Yonghong
Su, Zhiheng
author_sort Wang, Qianyi
collection PubMed
description Liver fibrosis is a pathological result of liver injury that usually leads to a pathophysiological wound healing response. The total alkaloids of Corydalis saxicola Bunting (TACS) have been used for hepatoprotective effects on the liver. However, its exact therapeutic mechanisms of liver fibrosis are not yet well understood. To explore the potential anti-fibrosis mechanism of TACS, metabolomics coupled with network pharmacology were applied to reveal the underlying mechanisms. Ultra-performance liquid chromatography quadrupole time-of-flight mass spectrometry (UPLC-Q-TOF/MS) combined with multivariate statistical analyses were performed to estimate changes in metabolic profiles. As a result, a total of 23 metabolites in rats with liver fibrosis were altered; of these, 11 had been downregulated and 12 had been upregulated compared with the control group. After TACS treatment, the levels of 13 metabolites were significantly restored compared with the CCl(4)-treated group, of which 4 metabolites were up-regulated and 9 metabolites were down-regulated. Many of these metabolites are involved in the bile acid metabolism, glutathione metabolism, tryptophan metabolism and purine metabolism. Then, three key targets, including cytochrome P450 family1 subfamily A member 1 (CYP1A1), ornithine decarboxylase 1 (OCD1) and monoamine oxidase Type B (MAOB) were predicted as potential therapeutic targets of TACS against liver fibrosis through network pharmacology analysis. Finally, palmatine, tetrahydropalmatine and dehydrocavidine were screened as potential active compounds responsible for the anti-fibrosis effect of TACS by molecular docking analysis. This study reveals that TACS exerted anti-fibrosis effects by regulating the liver metabolic pathway with multiple components and multiple targets, which is helpful to further clarify the hepatoprotective mechanisms of natural plant extracts.
format Online
Article
Text
id pubmed-9866371
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-98663712023-01-22 Investigation of the Therapeutic Effect of Total Alkaloids of Corydalis saxicola Bunting on CCl(4)-Induced Liver Fibrosis in Rats by LC/MS-Based Metabolomics Analysis and Network Pharmacology Wang, Qianyi Luo, Zhuo Li, Danfeng Qin, Jinghua Pan, Ziping Guo, Bingjian Deng, Lijun Nong, Yunyuan Huang, Zheng He, Ying Guo, Hongwei Zhu, Dan Liang, Yonghong Su, Zhiheng Metabolites Article Liver fibrosis is a pathological result of liver injury that usually leads to a pathophysiological wound healing response. The total alkaloids of Corydalis saxicola Bunting (TACS) have been used for hepatoprotective effects on the liver. However, its exact therapeutic mechanisms of liver fibrosis are not yet well understood. To explore the potential anti-fibrosis mechanism of TACS, metabolomics coupled with network pharmacology were applied to reveal the underlying mechanisms. Ultra-performance liquid chromatography quadrupole time-of-flight mass spectrometry (UPLC-Q-TOF/MS) combined with multivariate statistical analyses were performed to estimate changes in metabolic profiles. As a result, a total of 23 metabolites in rats with liver fibrosis were altered; of these, 11 had been downregulated and 12 had been upregulated compared with the control group. After TACS treatment, the levels of 13 metabolites were significantly restored compared with the CCl(4)-treated group, of which 4 metabolites were up-regulated and 9 metabolites were down-regulated. Many of these metabolites are involved in the bile acid metabolism, glutathione metabolism, tryptophan metabolism and purine metabolism. Then, three key targets, including cytochrome P450 family1 subfamily A member 1 (CYP1A1), ornithine decarboxylase 1 (OCD1) and monoamine oxidase Type B (MAOB) were predicted as potential therapeutic targets of TACS against liver fibrosis through network pharmacology analysis. Finally, palmatine, tetrahydropalmatine and dehydrocavidine were screened as potential active compounds responsible for the anti-fibrosis effect of TACS by molecular docking analysis. This study reveals that TACS exerted anti-fibrosis effects by regulating the liver metabolic pathway with multiple components and multiple targets, which is helpful to further clarify the hepatoprotective mechanisms of natural plant extracts. MDPI 2022-12-21 /pmc/articles/PMC9866371/ /pubmed/36676934 http://dx.doi.org/10.3390/metabo13010009 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Wang, Qianyi
Luo, Zhuo
Li, Danfeng
Qin, Jinghua
Pan, Ziping
Guo, Bingjian
Deng, Lijun
Nong, Yunyuan
Huang, Zheng
He, Ying
Guo, Hongwei
Zhu, Dan
Liang, Yonghong
Su, Zhiheng
Investigation of the Therapeutic Effect of Total Alkaloids of Corydalis saxicola Bunting on CCl(4)-Induced Liver Fibrosis in Rats by LC/MS-Based Metabolomics Analysis and Network Pharmacology
title Investigation of the Therapeutic Effect of Total Alkaloids of Corydalis saxicola Bunting on CCl(4)-Induced Liver Fibrosis in Rats by LC/MS-Based Metabolomics Analysis and Network Pharmacology
title_full Investigation of the Therapeutic Effect of Total Alkaloids of Corydalis saxicola Bunting on CCl(4)-Induced Liver Fibrosis in Rats by LC/MS-Based Metabolomics Analysis and Network Pharmacology
title_fullStr Investigation of the Therapeutic Effect of Total Alkaloids of Corydalis saxicola Bunting on CCl(4)-Induced Liver Fibrosis in Rats by LC/MS-Based Metabolomics Analysis and Network Pharmacology
title_full_unstemmed Investigation of the Therapeutic Effect of Total Alkaloids of Corydalis saxicola Bunting on CCl(4)-Induced Liver Fibrosis in Rats by LC/MS-Based Metabolomics Analysis and Network Pharmacology
title_short Investigation of the Therapeutic Effect of Total Alkaloids of Corydalis saxicola Bunting on CCl(4)-Induced Liver Fibrosis in Rats by LC/MS-Based Metabolomics Analysis and Network Pharmacology
title_sort investigation of the therapeutic effect of total alkaloids of corydalis saxicola bunting on ccl(4)-induced liver fibrosis in rats by lc/ms-based metabolomics analysis and network pharmacology
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866371/
https://www.ncbi.nlm.nih.gov/pubmed/36676934
http://dx.doi.org/10.3390/metabo13010009
work_keys_str_mv AT wangqianyi investigationofthetherapeuticeffectoftotalalkaloidsofcorydalissaxicolabuntingonccl4inducedliverfibrosisinratsbylcmsbasedmetabolomicsanalysisandnetworkpharmacology
AT luozhuo investigationofthetherapeuticeffectoftotalalkaloidsofcorydalissaxicolabuntingonccl4inducedliverfibrosisinratsbylcmsbasedmetabolomicsanalysisandnetworkpharmacology
AT lidanfeng investigationofthetherapeuticeffectoftotalalkaloidsofcorydalissaxicolabuntingonccl4inducedliverfibrosisinratsbylcmsbasedmetabolomicsanalysisandnetworkpharmacology
AT qinjinghua investigationofthetherapeuticeffectoftotalalkaloidsofcorydalissaxicolabuntingonccl4inducedliverfibrosisinratsbylcmsbasedmetabolomicsanalysisandnetworkpharmacology
AT panziping investigationofthetherapeuticeffectoftotalalkaloidsofcorydalissaxicolabuntingonccl4inducedliverfibrosisinratsbylcmsbasedmetabolomicsanalysisandnetworkpharmacology
AT guobingjian investigationofthetherapeuticeffectoftotalalkaloidsofcorydalissaxicolabuntingonccl4inducedliverfibrosisinratsbylcmsbasedmetabolomicsanalysisandnetworkpharmacology
AT denglijun investigationofthetherapeuticeffectoftotalalkaloidsofcorydalissaxicolabuntingonccl4inducedliverfibrosisinratsbylcmsbasedmetabolomicsanalysisandnetworkpharmacology
AT nongyunyuan investigationofthetherapeuticeffectoftotalalkaloidsofcorydalissaxicolabuntingonccl4inducedliverfibrosisinratsbylcmsbasedmetabolomicsanalysisandnetworkpharmacology
AT huangzheng investigationofthetherapeuticeffectoftotalalkaloidsofcorydalissaxicolabuntingonccl4inducedliverfibrosisinratsbylcmsbasedmetabolomicsanalysisandnetworkpharmacology
AT heying investigationofthetherapeuticeffectoftotalalkaloidsofcorydalissaxicolabuntingonccl4inducedliverfibrosisinratsbylcmsbasedmetabolomicsanalysisandnetworkpharmacology
AT guohongwei investigationofthetherapeuticeffectoftotalalkaloidsofcorydalissaxicolabuntingonccl4inducedliverfibrosisinratsbylcmsbasedmetabolomicsanalysisandnetworkpharmacology
AT zhudan investigationofthetherapeuticeffectoftotalalkaloidsofcorydalissaxicolabuntingonccl4inducedliverfibrosisinratsbylcmsbasedmetabolomicsanalysisandnetworkpharmacology
AT liangyonghong investigationofthetherapeuticeffectoftotalalkaloidsofcorydalissaxicolabuntingonccl4inducedliverfibrosisinratsbylcmsbasedmetabolomicsanalysisandnetworkpharmacology
AT suzhiheng investigationofthetherapeuticeffectoftotalalkaloidsofcorydalissaxicolabuntingonccl4inducedliverfibrosisinratsbylcmsbasedmetabolomicsanalysisandnetworkpharmacology